Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 11753595)

1.

Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P.

CMAJ Open. 2014 Oct 1;2(4):E306-17. doi: 10.9778/cmajo.20140012. eCollection 2014 Oct.

2.

Effects of orlistat plus diet on postprandial lipemia and brachial artery reactivity in normolipidemic, obese women with normal glucose tolerance: A prospective, randomized, controlled Study.

Turker I, Guvener Demirag N, Tanaci N, Uslu Tutar N, Kirbas I.

Curr Ther Res Clin Exp. 2006 May;67(3):159-73. doi: 10.1016/j.curtheres.2006.06.001.

3.

Effectiveness of weight loss interventions for obese older adults.

Felix HC, West DS.

Am J Health Promot. 2013 Jan-Feb;27(3):191-9. doi: 10.4278/ajhp.110617-LIT-259. Review.

4.

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.

Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators.

Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Erratum in: Int J Obes (Lond). 2012 Jun;36(6):890. Int J Obes (Lond). 2013 Feb;37(2):322.

5.
6.

Efficacy and tolerability of the association of sibutramine and orlistat for six months in overweight and obese patients.

Halpern A, Pepe RB, Monegaglia AP, Beyruti M, de Melo ME, Mancini MC.

J Obes. 2010;2010. pii: 602537. doi: 10.1155/2010/602537. Epub 2010 Feb 7.

7.

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Heal DJ, Gosden J, Smith SL.

Br J Clin Pharmacol. 2009 Dec;68(6):861-74. doi: 10.1111/j.1365-2125.2009.03549.x.

8.

Sample size in obesity trials: patient perspective versus current practice.

Allison DB, Elobeid MA, Cope MB, Brock DW, Faith MS, Vander Veur S, Berkowitz R, Cutter G, McVie T, Gadde KM, Foster GD.

Med Decis Making. 2010 Jan-Feb;30(1):68-75. doi: 10.1177/0272989X09340583. Epub 2009 Aug 12.

9.

Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.

Bryson A, de la Motte S, Dunk C.

Br J Clin Pharmacol. 2009 Mar;67(3):309-15. doi: 10.1111/j.1365-2125.2008.03311.x. Epub 2008 Sep 19.

10.

Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions.

McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA.

J Pediatr Endocrinol Metab. 2004 Mar;17(3):307-19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk